ARTICLE | Emerging Company Profile
Floral delivery
Why Azitra is engineering bacteria to address a root cause of eczema
December 16, 2016 9:33 PM UTC
Instability and poor penetration can make topical delivery of proteins and peptides into the skin inefficient and inconsistent. Azitra Inc. is using an engineered human commensal strain of bacteria to consistently deliver therapeutic proteins to the skin.
Azitra’s delivery technology uses Staphylococcus epidermidis to produce steady levels of the desired protein and attaches a penetration-enhancing peptide to the protein...
BCIQ Company Profiles
BCIQ Target Profiles